Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @psnresearch
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @psnresearch
-
Sermes CRO a PSN Research Company, has been awarded as the most Innovative Company Global Supplier 2019 by MSD global https://psnresearch.com/news pic.twitter.com/L8gd1Ap7oI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RCTs a PSNResearch Company in
@AFCROshttps://twitter.com/RCTs_FR/status/1090904031852220416 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
We thank
@Cytokinetics@biohavenPharma Italfarmaco & Martindale Pharma Mitsubishi Tanabe Pharma Europe@OrionPharma @MRPHarmaUS@psnresearch and Glasgow Convention Bureau for their support and@MNDScotland for hosting the 29th#alssymp!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FDA launches new office to rethink how drugs are reviewed https://psnresearch.com/news
@psnresearch@FundacionSermes@SermesCROpic.twitter.com/daMt4Njlsb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
Watch this video to find out how
#EMA monitors medicines once they are on the market: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/08/news_detail_003010.jsp&mid=WC0b01ac058004d5c1 …pic.twitter.com/L8j3IfGyR3Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
Read the Brexit-related guidance for companies prepared by
#EMA and the European Commission: http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_001891.jsp&mid=WC0b01ac0580cb2e5b …#Brexit@EU_Healthpic.twitter.com/rpyjkMJfrR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
Blood cancers don't just give up, so neither do we. CAR-T cell therapy could cure cancer where there are very little treatment options
#WeWontRest https://bit.ly/2sE9a7J pic.twitter.com/8PVza917GV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Do you know what happenned with the EMA´s Communication Perception Survey 2017??? See the results and Report https://psnresearch.com/news
@psnresearchpic.twitter.com/Ej7YOgSEh7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EMA’s publication of clinical data a success https://psnresearch.com/news
@psnresearchpic.twitter.com/4Q3sqUJYEo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How the EU Agencies contribute to the lives of everyone in Europe??? https://youtu.be/DwPI_ullrWo
@psnresearch https://psnresearch.com/newsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
La OMS publica su nueva Clasificación Internacional de Enfermedades (CIE-11)https://buff.ly/2vlQuNA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
#EMA and@EUnetHTA continue their collaboration at a meeting on 5 July. Topics covered include#ATMPs, labelling,#OrphanMedicines and#patient registries: http://bit.ly/2KRgDKB pic.twitter.com/NLAZ2QqdCJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Lymph node fibrosis: a structural barrier to unleashing effective vaccine immunity http://psnresearch.com/news pic.twitter.com/gIUHc5sgwV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Statement from FDA Commissioner, on agency’s continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug http://psnresearch.com/news
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
First two CAR-T cell medicines recommended for approval in the European Union http://psnresearch.com/news
@psnresearch@SermesCROpic.twitter.com/pLYnZLaVNb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
EFPIA President: Next EU Commission should prioritise competitiveness in pharma innovation
@EURACTIV@EFPIAhttps://www.euractiv.com/section/health-consumers/interview/efpia-president-next-eu-commission-should-prioritise-competitiveness-in-pharma-innovation/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
#EMA carried out a total of 925 activities involving#patients and 445 activities involving#HealthcareProfessionals during 2017. Read more in our latest Stakeholder Engagement report: http://bit.ly/2IvNnaf pic.twitter.com/0Voic7XJLP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
#RCTs and#PSNResearch will be at the#euroepi2018 held 4-6 July in#Lyon with the poster "EVALUATION OF THE IMPACT OF TERMINATING THE REIMBURSEMENT OF A THERAPEUTIC CLASS OF DRUGS ON THE FRENCH HEALTH SYSTEM". Join Karine Mari and Rafael Zurita to discuss your European studies.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
Are you a
#raredisease patient, family member or carer? Help us understand your views on the sharing and protection of your health data! Respond to a#RareBarometer survey by 31 March to share your views (survey available in 23 languages!): http://bit.ly/2u6cIFA@EU_Healthpic.twitter.com/WWoLh1kJnN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PSN Research proslijedio/la je Tweet
#CHMP recommends 6#medicines for approval at its March 2018 meeting https://bit.ly/2G0h1YI pic.twitter.com/v3ERejrJ4b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.